These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Urinary phenylethylamine correlates positively with hypomania, and negatively with depression, paranoia, and social introversion on the MMPI. Moises HW; Waldmeier P; Beckmann H Eur Arch Psychiatry Neurol Sci; 1986; 236(2):83-7. PubMed ID: 3792411 [TBL] [Abstract][Full Text] [Related]
4. Increase in urinary beta-phenylethylamine preceding the switch from mania to depression: a "rapid cycler". Semba J; Nankai M; Maruyama Y; Kaneno S; Watanabe A; Takahashi R J Nerv Ment Dis; 1988 Feb; 176(2):116-9. PubMed ID: 3339341 [TBL] [Abstract][Full Text] [Related]
5. Effect of low-dose clorgyline on 24-hour urinary monoamine excretion in patients with rapidly cycling bipolar affective disorder. Linnoila M; Karoum F; Potter WZ Arch Gen Psychiatry; 1982 May; 39(5):513-6. PubMed ID: 6178382 [TBL] [Abstract][Full Text] [Related]
6. Temporal association between depression-dependent dyskinesias and high urinary phenylethylamine output. Linnoila M; Karoum F; Cutler NR; Potter WZ Biol Psychiatry; 1983 Apr; 18(4):513-6. PubMed ID: 6860726 [No Abstract] [Full Text] [Related]
7. Amelioration of psychosis with carbidopa. A case report. Linnoila M; Karoum F; Potkin SG; Wyatt RJ; Potter WZ Br J Psychiatry; 1984 Apr; 144():428-31. PubMed ID: 6722403 [TBL] [Abstract][Full Text] [Related]
12. Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia. Yoshimoto S; Kaku H; Shimogawa S; Watanabe A; Nakagawara M; Takahashi R Psychiatry Res; 1987 Jul; 21(3):229-36. PubMed ID: 3628609 [TBL] [Abstract][Full Text] [Related]
13. Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders. Schatzberg AF; Samson JA; Bloomingdale KL; Orsulak PJ; Gerson B; Kizuka PP; Cole JO; Schildkraut JJ Arch Gen Psychiatry; 1989 Mar; 46(3):260-8. PubMed ID: 2783211 [TBL] [Abstract][Full Text] [Related]
14. Biochemical effects of L-deprenyl in atypical depressives. Liebowitz MR; Karoum F; Quitkin FM; Davies SO; Schwartz D; Levitt M; Linnoila M Biol Psychiatry; 1985 May; 20(5):558-65. PubMed ID: 3921065 [TBL] [Abstract][Full Text] [Related]
15. [Excretion of 3,4-dimethoxy phenylethylamine in the urine of schizophrenics]. Zimmermann K; Moschke P; Wieder KH Psychiatr Neurol Med Psychol (Leipz); 1976 Mar; 28(3):163-73. PubMed ID: 967948 [TBL] [Abstract][Full Text] [Related]
16. Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. A replication and new findings. Muscettola G; Potter WZ; Pickar D; Goodwin FK Arch Gen Psychiatry; 1984 Apr; 41(4):337-42. PubMed ID: 6703853 [TBL] [Abstract][Full Text] [Related]
17. Changes in norepinephrine output following light therapy for fall/winter seasonal depression. Anderson JL; Vasile RG; Mooney JJ; Bloomingdale KL; Samson JA; Schildkraut JJ Biol Psychiatry; 1992 Oct; 32(8):700-4. PubMed ID: 1457625 [TBL] [Abstract][Full Text] [Related]
18. The determination of urinary 3-methoxy-4-hydroxyphenylglycol excretion in acute schizophreniform and depressed patients. DeLisi LE; Karoum F; Targum S; Byrnes S; Wyatt RJ Biol Psychiatry; 1983 Oct; 18(10):1189-96. PubMed ID: 6652159 [No Abstract] [Full Text] [Related]
19. High urinary norepinephrine excretion in major depressive disorders: effects of a new type of MAO inhibitor (Moclobemide, RO 11-1163). Dajas F; Lista A; Barbeito L Acta Psychiatr Scand; 1984 Nov; 70(5):432-7. PubMed ID: 6516893 [TBL] [Abstract][Full Text] [Related]
20. The tyramine challenge test as a marker for melancholia. Harrison WM; Cooper TB; Stewart JW; Quitkin FM; McGrath PJ; Liebowitz MR; Rabkin JR; Markowitz JS; Klein DF Arch Gen Psychiatry; 1984 Jul; 41(7):681-5. PubMed ID: 6732426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]